x
Filter:
Filters applied
- Editorials
- Lee, StephanieRemove Lee, Stephanie filter
- Haft, Michael ARemove Haft, Michael A filter
- 2017 - 2022Remove 2017 - 2022 filter
- Annals of Allergy, Asthma & ImmunologyRemove Annals of Allergy, Asthma & Immunology filter
Editorials
1 Results
- CME Review
Atopic dermatitisReview of comorbidities and therapeutics
Annals of Allergy, Asthma & ImmunologyVol. 129Issue 2p142–149Published online: May 21, 2022- Margaret M. Appiah
- Michael A. Haft
- Elana Kleinman
- Jennifer Laborada
- Stephanie Lee
- Lauren Loop
- and others
Cited in Scopus: 6Atopic dermatitis (AD) is a very common skin disease associated with substantial burdens on patient health and quality of life. Knowledge regarding the pathogenesis of AD has expanded within recent years, leading to novel and efficacious therapeutic agents. Similarly, our knowledge of the impact of AD on patient's mental and physical health has also expanded. This review summarizes updates on the evolution, comorbidities, and therapeutic options of AD. AD is associated with increased cardiovascular risk, allergic diseases, and adverse mental health outcomes.